Flu & Viruses
-
Lung function not affected in young adults with COVID-19
COVID-19 does not affect the lung function of young adults, according to the first study of its kind. Read more
-
Cancer treatment hope from Oxford COVID vaccine technology
The technology behind the Oxford-AstraZeneca COVID-19 vaccine could be used to help treat cancer, it is revealed today. Read more
-
Long COVID concerns among teens – but teachers safe
Large numbers of children and teenagers who contracted COVID-19 may be suffering from long COVID, according to a major new analysis. Read more
-
Insight into COVID antibody failure
Around one in five infected people do not develop antibodies to COVID-19, according to a new study. Read more
-
Low-cost health solutions to turn pandemic tide
Low cost and innovative health technologies could help the developing world combat the threat of COVID, the World Health Organization has reported. Read more
-
COVID causes much more blood disease than vaccines – major analysis
The risk of blood clotting diseases caused by the COVID-19 vaccines is significantly outweighed by the risk of being infected with the virus and contracting those same diseases, British researchers say today. Read more
-
COVID-19 economic downturn caused excess infant deaths
The economic downturn in low and middle income countries caused by COVID-19 is likely to have caused an additional 267,000 infants’ deaths in 2020, according to an analysis published today. Read more
-
Major programme to trace antibody role in virus susceptibility
A new UK COVID antibody surveillance programme will seek to establish the limits of the vaccination programme, it has been announced. Read more
-
Delta weakening vaccine impact – UK data analysis
The Delta variant has significantly reduced the effectiveness of the UK’s COVID vaccination programme, according to the findings of a major new study. Read more
-
Plea for funds against global Delta threat
A major appeal has been launched for funds to tackle the global threat of the Delta variant of COVID-19. Read more
